Advent Life Sciences

We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focused on new drug discovery across all modalities, med tech, enabling technologies and vaccines.

Below, you can browse the investment details of Advent Life Sciences and qualify how well they align with your fundraising goals. You can access their full contact details and your calculated match score on Hopohopo.io.

?
Match score

Investment thesis

Advent Life Sciences focuses on innovative businesses in biotechnology, pharmaceuticals, medical devices, diagnostics, and enabling technologies. The firm seeks ventures with strong scientific foundations and the potential to transform patient care through innovative therapies and technologies.

Invest in

  • Baltics
  • Nordics
  • Western Europe
  • Southern Europe
  • Central Eastern Europe
  • North America

Customer types

  • B2B2C
  • Consumers
  • Governments
  • Large enterprises
  • Small and medium enterprises

Product type

  • Hardware
  • Software
  • Software-enabled hardware

Industries / verticals

  • BioTech
  • HealthTech / MedTech
  • Life Science
adventls.com/
LinkedIn

Investment details

Investment role

Lead and follow

Stages

Pre-seed, Seed, Series A, Series B or later

First ticket size

£1,000,000 - £10,000,000

Related contacts

General Partner

Shahzad Malik

LinkedIn Email

General Partner

Raj Parekh

LinkedIn Email

Venture Partner

Katrine Bosley

LinkedIn Email

Venture Partner

Don Drakeman

LinkedIn Email

Explore more investors like Advent Life Sciences:

or discover the best-fitting investors for your startup with Hopohopo.io.

Investor funnel board